U.S. markets open in 1 hour 20 minutes
  • S&P Futures

    3,459.25
    +10.00 (+0.29%)
     
  • Dow Futures

    28,352.00
    +84.00 (+0.30%)
     
  • Nasdaq Futures

    11,669.25
    +19.50 (+0.17%)
     
  • Russell 2000 Futures

    1,639.70
    +9.10 (+0.56%)
     
  • Crude Oil

    40.80
    +0.16 (+0.39%)
     
  • Gold

    1,914.00
    +9.40 (+0.49%)
     
  • Silver

    24.87
    +0.16 (+0.65%)
     
  • EUR/USD

    1.1862
    +0.0036 (+0.31%)
     
  • 10-Yr Bond

    0.8480
    0.0000 (0.00%)
     
  • Vix

    27.71
    -0.94 (-3.28%)
     
  • GBP/USD

    1.3080
    +0.0000 (+0.00%)
     
  • USD/JPY

    104.6900
    -0.1500 (-0.14%)
     
  • BTC-USD

    12,953.31
    -13.43 (-0.10%)
     
  • CMC Crypto 200

    261.56
    +5.46 (+2.13%)
     
  • FTSE 100

    5,878.25
    +92.60 (+1.60%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Galectin Therapeutics (GALT) Jumps: Stock Rises 15.1%

Zacks Equity Research

Galectin Therapeutics Inc. GALT was a big mover last session, as the company saw its shares rise more than 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.54 to $2.98 in the past one-month time frame.

The company has seen three positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Galectin Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Galectin Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Galectin Therapeutics Inc. Price

Galectin Therapeutics Inc. Price | Galectin Therapeutics Inc. Quote

A better-ranked stock worth considering in the Medical sectoris ArQule, Inc. ARQL which carries a Zacks Rank #2 (Buy).You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is GALT going up? Or down? Predict to see what others think: Up or Down.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Galectin Therapeutics Inc. (GALT) : Free Stock Analysis Report
 
ArQule, Inc. (ARQL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research